Impact ledger
Bicycle Therapeutics plc (BCYC)
2 events mapped to this ticker since 2026-06-12.
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-18 | Event | Investor sentiment and corporate governance. The results of shareholder votes, particularly on executive compensation, board composition, or significant corporate actions, can influence investor perception of management's alignment with shareholder interests and overall corporate governance. | watch | 1-5d | 0.30 |
| 2026-06-12 | Event | Increased competitive pressure in the hereditary angioedema (HAE) market. KalVista's lead product, sebetralstat, is an oral on-demand treatment for HAE, which could compete with existing or pipeline HAE treatments. | watch | 1-3m | 0.20 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for BCYC, start a trial or view the BCYC entity page.